ibandronic acid has been researched along with Chronic Illness in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lo, JC; O'Ryan, FS | 1 |
Bauss, F; Brkovic, D; Jakse, G; Linke, J | 1 |
Bianchi, M; Ferrario, P; Franchi, S; Sacerdote, P; Sotgiu, ML | 1 |
Amos, N; Richards, PJ; Williams, AS; Williams, BD | 1 |
4 other study(ies) available for ibandronic acid and Chronic Illness
Article | Year |
---|---|
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antirheumatic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Chronic Disease; Cohort Studies; Debridement; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Ibandronic Acid; Male; Middle Aged; Osteolysis; Osteoporosis; Osteosclerosis; Retrospective Studies; Tooth Extraction; Treatment Outcome; Wound Healing | 2012 |
Changes in bone structure after augmentation cystoplasty in chronic uraemic rats.
Topics: Animals; Bone Density; Bone Resorption; Chronic Disease; Diphosphonates; Female; Ibandronic Acid; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Uremia; Urinary Diversion | 2005 |
Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cytokines; Dinoprostone; Diphosphonates; Drug Evaluation, Preclinical; Edema; Foot; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Ibandronic Acid; Inflammation; Interleukin-1beta; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tumor Necrosis Factor-alpha | 2008 |
Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo.
Topics: Animals; Antibodies, Monoclonal; Antigens; Arthritis; Chronic Disease; Diphosphonates; DNA Primers; Flow Cytometry; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; Ibandronic Acid; In Vitro Techniques; Injections, Intra-Articular; Interferon-gamma; Knee Joint; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Male; Neutralization Tests; Polymerase Chain Reaction; Rats; Rats, Inbred Lew; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |